Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Non-ablative Er:YAG laser effectively treats hair loss with high patient satisfaction and no side effects.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Collagen from tilapia scales may improve hair and skin health by reducing stress and inflammation and encouraging hair growth.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Korean medicine may help with hair growth in alopecia, but more research is needed to confirm this.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Afatinib often causes skin problems that need proactive management.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Ayurvedic medicine helped increase a young woman's hemoglobin levels and improved her anemia symptoms.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Bicalutamide improves hair density in women safely.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

PRP injections improve hair density and thickness in women with hair loss.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.